Elutia (ELUT) Liabilities from Discontinued Operations (2022 - 2025)

Elutia (ELUT) posted Liabilities from Discontinued Operations of 357000.0 for Q3 2025, up 13.33% sequentially from 315000.0 in Q4 2024.

Elutia (ELUT) Liabilities from Discontinued Operations (2022 - 2025) Analysis & Trends

Elutia has reported Liabilities from Discontinued Operations for 4 years, with the latest figure at 357000.0 in Q3 2025.

Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 357000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 357000.0 (changed N/A YoY) and the FY2024 annual result came in at 315000.0, changed N/A from the prior year.
Liabilities from Discontinued Operations grew to 357000.0 in Q3 2025 per ELUT's latest filing, from 315000.0 in the prior quarter.
Over five years, Liabilities from Discontinued Operations peaked at 4929000.0 in Q4 2022 and troughed at 315000.0 in Q4 2024.
A 4-year average of 2197750.0 and a median of 1773500.0 in 2023 frame the typical range for Liabilities from Discontinued Operations.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Elutia	40.75 Mn	20.85 Mn	1.45 Mn

Download Data